It has been reported that the PI3K/Akt/mTOR signaling pathway plays a crucial role in the proteolytic processing of PFK1, from 85 kDa to 49 kDa fragments, in breast and prostate cancer cell lines [54,55]. Here, PFKM is linked to prostate carcinoma.